Sara Galimberti

14PUBLICATIONS
58CO-AUTHORS
Predictive and prognostic markersHaematological tumoursCardiology (incl. cardiovascular diseases)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Clinimetrics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|Nov 07, 2025
The integration of gene mutations and copy number variations refines the prognosis of mantle cell lymphoma: long-term results of the Fondazione Italiana Linfomi MCL0208 clinical trial.

Riccardo Moia, Simone Ragaini, Luciano Cascione

|Sep 10, 2024
A new digital droplet PCR method for looking at epigenetics in diffuse large B-cell lymphomas: The role of BMI1, EZH2, and USP22 genes.

Alessio Lusci Gemignani, Robel Papotti, Riccardo Bomben

|Aug 30, 2023
Risk of progression in chronic phase-chronic myeloid leukemia patients eligible for tyrosine kinase inhibitor discontinuation: Final analysis of the TFR-PRO study.

Giovanni Paolo Maria Zambrotta, Franck E Nicolini, Sarit Assouline

|Aug 03, 2021
The JAK-STAT pathway: an emerging target for cardiovascular disease in rheumatoid arthritis and myeloproliferative neoplasms.

Chiara Baldini, Francesca Romana Moriconi, Sara Galimberti

|May 14, 2021
TP53 disruption as a risk factor in the era of targeted therapies: A multicenter retrospective study of 525 chronic lymphocytic leukemia cases.

Fortunato Morabito, Giovanni Del Poeta, Francesca Romana Mauro

|Apr 20, 2021
Effectiveness of ibrutinib as first-line therapy for chronic lymphocytic leukemia patients and indirect comparison with rituximab-bendamustine: Results of study on 486 cases outside clinical trials.

Fortunato Morabito, Giovanni Tripepi, Giovanni Del Poeta

Pageof 3

Frequent Collaborators

4 joint publications

Riccardo Moia

3 joint publications

Alessandra Iurlo

3 joint publications

Gianluigi Reda

3 joint publications

Marzia Varettoni